US20030082601A1 - Enzyme-amplified redox microarray detection process - Google Patents
Enzyme-amplified redox microarray detection process Download PDFInfo
- Publication number
- US20030082601A1 US20030082601A1 US10/229,755 US22975502A US2003082601A1 US 20030082601 A1 US20030082601 A1 US 20030082601A1 US 22975502 A US22975502 A US 22975502A US 2003082601 A1 US2003082601 A1 US 2003082601A1
- Authority
- US
- United States
- Prior art keywords
- molecules
- electrodes
- capture
- target molecule
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
Definitions
- the present invention provides a process and an array for assaying for binding of target molecules to capture molecules on microarray devices, wherein the mircoarray devices contain electrodes.
- the present invention provides a binding (including nucleotide hybridization) process to detect binding on a microarray wherein the microarray contains electronically addressable electrode devices.
- the inventive detection process further provides for an enzymatically catalyzed oxidation/reduction reaction to take place within a “virtual flask” region of a microarray wherein the reaction is detected by current changes detected on the addressable electrode.
- microarrays In the world of microarrays or biochips, biological molecules (e.g., oligonucleotides, polypeptides, oligopeptides and the like) are placed onto surfaces at defined locations for potential binding with target samples of nucleotides or receptors or other molecules.
- Microarrays are miniaturized arrays of biomolecules available or being developed on a variety of platforms. Much of the initial focus for these microarrays have been in genomics with an emphasis of single nucleotide polymorphisms (SNPs) and genomic DNA detection/validation, functional genomics and proteomics (Wilgenbus and Lichter, J. Mol. Med. 77:761, 1999; Ashfari et al., Cancer Res.
- SNPs single nucleotide polymorphisms
- oligonucleotide microarrays also called “biochips” and “DNA Arrays” and “Gene Chips” but this descriptive name has been attempted to be a trademark
- the oligonucleotide microarrays have a solid surface, usually silicon-based and most often a glass microscopic slide.
- Oligonucleotide microarrays are often made by different techniques, including (1) “spotting” by depositing single nucleotides for in situ synthesis or completed oligonucleotides by physical means (ink jet printing and the like), (2) photolithographic techniques for in situ oligonucleotide synthesis (see, for example, Fodor U.S. Pat.
- oligonucleotides in situ that are, building each oligonucleotide, nucleotide-by-nucleotide, on the microarray surface without placing or attracting fully formed oligonucleotides.
- this involves “spotting” relevant single nucleotides at the exact location or region on a slide (preferably a glass slide) where a particular sequence of oligonucleotide is to be built. Therefore, irrespective of whether or not fully formed oligonucleotides or single nucleotides are added for in situ synthesis, spotting techniques involve the precise placement of materials at specific sites or regions using automated techniques.
- Another technique involves a photolithography process involving photomasks to build oligonucleotides in situ, base-by-base, by providing a series of precise photomasks coordinated with single nucleotide bases having light-cleavable blocking groups.
- This technique is described in Fodor et al. U.S. Pat. No. 5,445,934 and it's various progeny patents. Essentially, this technique provides for “solid-phase chemistry, photolabile protecting groups, and photolithography . . . to achieve light-directed spatially-addressable parallel chemical synthesis.” Binary masks are used in the preferred embodiment
- the electrochemistry platform (Montgomery U.S. Pat. No. 6,093,302, the disclosure of which is incorporated by reference herein) provides a microarray based upon a semiconductor chip platform having a plurality of microelectrodes.
- This chip design uses Complimentary Metal Oxide Semiconductor (CMOS) technology to create high-density arrays of microelectrodes with parallel addressing for selecting and controlling individual microelectrodes within the array.
- CMOS Complimentary Metal Oxide Semiconductor
- the electrodes turned on with current flow generate electrochemical reagents (particularly acidic protons) to alter the pH in a small and defined “virtual flask” region or volume adjacent to the electrode.
- the microarray is coated with a porous matrix for a reaction layer material. Thickness and porosity of the material is carefully controlled and biomolecules are synthesized within volumes of the porous matrix whose pH has been altered through controlled diffusion of protons generated electrochemically and whose diffusion
- microarray systems have detection processes generally using some form of photon-based detection. That is, most detection processes use fluorescent probes (alternatively visible dyes or luminescent probes) attached to “target” DNA sequences to detect binding or hybridization to an oligonucleotide capture probe attached on a microarray. Depending upon the intensity of the signal, such microarrays having probes to show hybridization have to be read through laser confocal microscope-based system for microarrays configured in a monolayer (such as those microarrays made through high density spotting or photolithography techniques) or by a video-type camera (such as a CCD camera) for those microarrays having a three-dimensional matrix for each spot in high density formats.
- fluorescent probes alternatively visible dyes or luminescent probes
- a video-type camera such as a CCD camera
- the present invention was made to address this need and to provide a detection system that can generate a more objective “yes” or “no” answer for each site in high-density microarray detection.
- the present invention provides a process for reading microarray devices having addressable electrodes to determine binding between a capture probe and a target molecule, comprising:
- the array having a plurality of electrodes and capture molecules corresponding to the electrodes is generated by a technique selected from the group consisting of in situ synthesis with electrochemical techniques, spotting the capture molecules, ink-jet printing the capture molecules, and in situ synthesis through photolighography techniques.
- the array having a plurality of electrodes and capture molecules corresponding to the electrodes is formed by in situ synthesis with electrochemical techniques.
- the oxidation/reduction enzyme is selected from the group consisting of laccase, horseradish peroxidase, ⁇ -galactosidase, glucose oxidase, alkaline phosphatase, dehydrogenases, and combinations thereof.
- the oxidation/reduction enzyme is attached to the target molecule(s) through an antibody and anti-idiotype antibody combination or through a biotin and streptavidin (or avidin) binding combination.
- the array having a plurality of electrodes further comprises a porous reaction layer covering the electrodes, wherein the porous reaction layer has a thickness of from about 0.1 microns to about 10 microns and whereby the porous reaction layer functions to block diffusion of oxidation/reduction activity products such that there is little lateral signal being picked up at an adjacent electrode.
- the porous reaction layer is made from a polymeric material selected from the group consisting of polyvinyl alcohol, polyvinyl acetate, dextran, complex polysaccharides, epoxy-based polymers, tricellulose acetate, polyurethane, agarose, controlled porosity glass with a PTFE resin, and combinations thereof.
- the capture molecule is a molecule from the class of molecules selected from the group consisting of oligonucleotides, polypeptides, antibodies, glycosylated polypeptides, polysaccharides, and mixed molecules having monomers from a plurality of the foregoing molecules.
- the target molecule is one likely to bind to at least one of a plurality of capture molecules.
- a target molecule is from a class of molecules selected from the group consisting of DNA, RNA, single-stranded DNA, ribosomal RNA, mitochondrial DNA, cellular receptors (i.e., glycosylated or non-glycosylated membrane-bound proteins), polypeptides, glycosylated polypeptides, antibodies, cellular antigenic determinants, organic molecules, metal ions, salt anions and cations, and combinations thereof.
- the present invention further provides a mircoarray device for detecting binding of a target molecule to a capture probe, comprising:
- the array having a plurality of electrodes and capture molecules corresponding to the electrodes is generated by a technique selected from the group consisting of in situ synthesis with electrochemical techniques, spotting the capture molecules, ink-jet printing the capture molecules, and in situ synthesis through photolighography techniques.
- the array having a plurality of electrodes and capture molecules corresponding to the electrodes is formed by in situ synthesis with electrochemical techniques.
- the oxidation/reduction enzyme is selected from the group consisting of laccase, horseradish peroxidase, ⁇ -galactosidase, glucose oxidase, alkaline phosphatase, dehydrogenases, and combinations thereof.
- the oxidation/reduction enzyme is attached to the target molecule(s) through an antibody and anti-idiotype antibody combination or through a biotin and streptavidin (or avidin) binding combination.
- the array having a plurality of electrodes further comprises a porous reaction layer covering the electrodes, wherein the porous reaction layer has a thickness of from about 0.1 microns to about 10 microns and whereby the porous reaction layer functions to block diffusion of oxidation/reduction activity products such that there is little lateral signal being picked up at an adjacent electrode.
- the porous reaction layer is made from a polymeric material selected from the group consisting of polyvinyl alcohol, polyvinyl acetate, polyvinyl alcohol, tricellulose acetate, complex polysaccharides, polyurethane, agarose, controlled porosity glass with a PTFE resin, dextran, epoxy-based polymers, and combinations thereof.
- the capture molecule is a molecule from the class of molecules selected from the group consisting of oligonucleotides, polypeptides, antibodies, glycosylated polypeptides, polysaccharides, and mixed molecules having monomers from a plurality of the foregoing molecules.
- the target molecule is one likely to bind to at least one of a plurality of capture molecules.
- a target molecule is from a class of molecules selected from the group consisting of DNA, RNA, single-stranded DNA, ribosomal RNA, mitochondrial DNA, cellular receptors (i.e., glycosylated or non-glycosylated membrane-bound proteins), polypeptides, glycosylated polypeptides, antibodies, cellular antigenic determinants, organic molecules, metal ions, salt anions and cations, and combinations thereof.
- FIG. 1 shows the chemical reaction scheme when using horseradish peroxidase (HRP) as the oxidation/reduction enzyme.
- the targeted molecule is AGP ( ⁇ -1 acid glycoprotein) that has been complexed with HRP by adding a biotin-labeled antibody specific for an epitope of AGP.
- the target molecule is complexed with HRP by adding an avidin-labeled HRP enzyme.
- the mircoarray site used for detecting AGP as the target molecule has another antibody binding to a different epitope on AGP as the capture molecule.
- the first antibody (labeled “Ab1”) is self-assembled to an oligonucleotide mircoarray through a tag array capture probe.
- FIG. 2 shows a similar configuration for detecting AGP as a known site on a mircoarray, except this complex uses the multimeric nature of streptavidin to capture both biotin-labeled second antibody bound to a second epitope on AGP and biotin-labeled different oxidation/reduction enzyme laccase.
- FIG. 3 shows the chemistry of the oxidation/reduction reaction when ⁇ -galactosidase is the oxidation/reduction enzyme and X-Gal (5-bromo-4-chloro-3-indoyl- ⁇ -D-ganactopyranoside) is the substrate.
- the reaction forms indigo blue and generates electrochemical reactants.
- the reaction is carried out at about pH 7.0 in 0.01 M phosphate buffer (PBS) with 1 mM Fe 2+ /Fe 3+ .
- PBS phosphate buffer
- the X-Gal should be present in saturation amounts.
- FIG. 4 shows the chemical reaction scheme when using glucose oxidase as the enzyme for oxidation reduction. Electrochemical reagents are generated with PMS (5-methyl-phenazinium methyl sulfate) as the substrate.
- FIG. 5 shows a reaction scheme with HRP (horse radish peroxidase) as the oxidation/reduction enzyme and catechol as the substrate.
- HRP horseradish peroxidase
- FIG. 6 shows a 3D plot of the amperometric measurement of ⁇ -galactosidase in an immunoassay detection system.
- Microarray chips were electrochemically modified with a biotin-containing reagent. In one section of the chip represented by lanes 1-8, no biotin tag was placed. In lanes 9-16, biotinylated ⁇ -galactosidase was bound using a biotin-streptavidin-biotin complex. Redox reagents and substrates were added according to the reaction scheme in FIG. 3. These data show an amperometric response difference in the two parts of the chip, that is, lanes 1-8 versus lanes 9-16 containing ⁇ -galactosidase.
- FIG. 7 shows a chip profile plot taken from a slice or row of the 3D plot from FIG. 6, wherein electrodes 9, 11, 13 and 15 contain ⁇ -galactosidase (bound in the region above the electrodes) and register a negative electrochemical signal. Therefore there is a positive result through the inventive electrochemical detection process at spots 9, 11, 13 and 15.
- FIG. 8 shows binding and detection of a fluorescein-labeled ⁇ -galactosidase using an amperometric technique showing redox detection results.
- the fluorescein acted as a low molecular weight antigen attached to the larger enzyme.
- the oxidation/reduction enzyme capture was made possible by placement of an affinity-tagged anti-fluorescein antibody on alternating electrodes in row S2. These data show that those known locations associated with electrodes having fluorescein-labeled ⁇ -galactosidase showed enhanced signals. Moreover, these data were verified using epi-fluorescent microscopy to confirm the electrochemical results.
- FIG. 9 shows a slice of a 3D plot created for the capture and detection of glucose oxidase as the oxidation/reduction enzyme.
- the glucose oxidase specific affinity tags are located in lanes 1-8.
- the glucose oxidase systems had higher background signals than other oxidation/reduction enzymes.
- FIG. 10 shows a plot of a voltage versus current display for HRP (horse radish peroxidase) as a redox curve monitored by a single 100 micron diameter electrode on a bare (i.e., no in situ synthesis of biomolecules) mircoarray chip.
- HRP horseradish peroxidase
- FIG. 11 shows the data from FIG. 10 in an amperometric experiment performed over a time course in a plot of current versus time for the peroxidase reaction. It should be noted that the current flow levels off after a period of a few minutes.
- FIG. 12 shows an amperometric 3D plot and visualized image for antibodies against AGP, Phage, BV (bacilovirus) spores, and RCA bound to electrodes through oligos P-5, P-6, P-7 and P-8, respectively.
- FTIC was bound to electrodes through oligo P-1.
- Corresponding antigens were detected by a complex of corresponding secondary antibodies conjugated with HRP.
- ODP/H 2 O 2 was used as the enzyme substrate.
- FIG. 13 shows a similar plot of goat IgG bound to electrodes S1 (1, 3 and 5) and S2 (2, 4 and 6) through oligonucleotide tagging. Detection of goat IgG was made by a complex of mouse anti-goat monoclonal antibody conjugated with HRP. FIG. 13 reverses the sign of current flow for better visualization.
- FIG. 14 shows a 3D plot for oligonucleotide hybridization electrochemical detection.
- oligo 6 and oligo 5 oligonucleotide sequences were in situ synthesized on an electrode containing mircoarray device.
- the chip was set up in an alternating electrode-counter electrode format having a checkerboard pattern of sites having an oligo 6 or oligo 5 oligonucleotide capture probe sequence surrounded diagonally by counter electrodes without oligonucleotides synthesized thereon.
- Target oligo5/6 sample (Operon) was treated to form single-stranded DNA (Operon) and biotinylated with oligo complement (Operon) according to manufacturers instructions.
- Streptavidin conjugated with HRP (Sigma) was added to the biotinylated oligo 5/6 sequence complement to form a target complex or complementary oligo 5/6 affinity-bound to HRP.
- FIG. 14 show a positive signal in a checkerboard for oligo 6 and oligo 5 oligonucleotide capture probes and the bottom panel showing no signal for rabbit sequence captures probes.
- OPD orthophenylamine diamine
- FIG. 15 shows the detection of Rab-biotin at a 100 pM concentration versus a silver/silver chloride reference electrode. Detection was measured with electrical potential (rather than current).
- the microarray used was coated with a PVA (polyvinyl acetate) porous matrix and OPD/H 2 O 2 was used as the enzymatic substrate.
- FIG. 16 shows calibration curves for detecting AGP (left) and RCA (right). The log plots show the extreme sensitivity of the inventive process.
- FIG. 17 shows the dependence of the amperometric signal on a log concentration of a Rab-biotin oligonucleotide on electrode-containing microarray devices coated with a poly-dextran porous matrix.
- the incubation time was 2 hours at 40° C. incubation temperature.
- Electrode-based microarrays can be made with various oligomers attached to predefined regions, wherein each predefined region is defined by the presence of an addressable electrode.
- An addressable electrode is one where it can be electronically accessed to create a current or voltage.
- Electrode-based microarrays further and often comprise a porous matrix layer that holds the capture molecules and provides a three dimensional virtual flask (cylindrical in the case of a circular electrode).
- the porous matrix layer is a membrane, wherein the membrane material is selected from the group consisting of polyvinyl alcohol, polyvinyl acetate, polyvinyl alcohol, tricellulose acetate, polyurethane, agarose, controlled porosity glass with a PTFE resin, and combinations thereof.
- the microarray contains a plurality (on in rare cases only one) of capture molecules.
- the capture molecules are oligonucleotides than can bind to complementary sequence regions (or nearly complementary sequence regions depending upon the hybridization conditions) of DNA or mRNA from the target samples. The challenge next becomes how one can detect this binding event or hybridization event.
- sample labeling kits Commercially available that cause the sample nucleic acid to become labeled with a fluorescent dye. Often it is a fluorescent dye sold under the trademarks of Texas Red®, or Cy® Dyes Cy3 and Cy5.
- the microarray is “read” through a common fluorometer arrangement with either microscopic magnification or imaging stitching and looking for fluorescence at the known locations where the capture molecule was spotted or synthesized. This common technique of fluorescent detection of microarrays using a standard fluorometer configuration with a microarray is the detection method universally used.
- the present inventive method uses electrochemical reagents generated locally within a porous reaction layer or membrane to only locally provide current or voltage to a nearby electrode, whose current or voltage signal can be detected at the nearby electrode and not “cross-talk” onto neighboring electrodes.
- Immunoassays are based generally upon antibody binding to another molecule, generally a protein sugar or glycoprotein.
- the problems of immunoassays are generally detection of this binding event.
- the sandwich based immunoassays are based upon the fact that one antibody has already been attached to the surface of the chip (the capture antibody; most often a monoclonal).
- the analyte is then bound to the antibody and a second antibody (usually polyclonal) is added for use as a reporter group.
- the second reporter antibody will generally contain a fluorophore or have an enzyme covalently attached.
- the reporter antibody may contain a biotin molecule. To this biotin molecule, a streptavidin-enzyme conjugate can be an attached.
- the inventive process can be constructed with immunoassays, even sandwich-type immunoassays by providing for the oxidation/reduction enzyme to be attached to a complex formed when binding to a capture molecule (i.e., first antibody) occurs.
- a capture molecule i.e., first antibody
- the latter assay formats allows a host of generic assay format to be designed without performing the grueling task of providing (synthesizing) analyte-based individual antibody-enzyme conjugates. Examples of immunoassays in a sandwich configuration are shown in FIGS. 1 and 2.
- HRP horse radish peroxidase reaction scheme with catechol as the substrate is shown in FIG. 5.
- HRP substrates include, for example, OPD (orthophenylene diamine), aminophenols and aromatic polyamines.
- the product (quinone) was detected amperometrically.
- the first assay was performed at ⁇ 0.3 V versus Pt wire in 0.05 M Na-citrate-phosphate buffer pH 5.0 containing 0.2 M Na 2 SO 4 .
- Catechol and hydrogen peroxide in 1 mM concentration were used as an enzymatic substrate.
- a proper checkerboard pattern from the microarray showed that binding occurred at the proper locations without the presence of noise or cross talk bleeding over to neighboring electrode locations.
- a second assay was performed at ⁇ 0.3 V vs. Pt wire in 0.05 M Na-citrate-phosphate buffer pH 5.0 containing 0.2 M Na 2 SO 4 .
- Catechol in 1 mM concentration was used as an enzymatic substrate. This reaction scheme also produced the expected binding results and followed the reaction scheme as follows:
- ⁇ -Galactosidase reaction cleaves penultimate ⁇ -galactose residues from oligosaccharides or from glycosyl derivatives.
- the reaction scheme is shown in FIG. 3.
- the substrate used was X-Gal, which is an indolyl derivative of ⁇ -galactopyranoside.
- Biotinylated ⁇ -galactosidase was purchased for studies. The reactions were carried out at pH 7.0 in PBS buffer, 0.01 M. A given quantity of X-Gal was dissolved in DMF (very soluble) so that when it was added to the aqueous buffer, a substrate concentration of about 0.1 mM was achieved (saturation).
- the X-Gal/DMF solution was added while vigorously vortexing the aqueous phase because of the limited solubility of the X-Gal water. If the DMF/X-Gal solution is added without vigorous vortexing, the X-Gal would precipitate from solution. The instability of this solution requires that a fresh solution needs to be prepared daily.
- an organic substrate such as catechol
- the turnover rate for this enzyme is lower than that for other redox enzymes, but the enzyme is very stable at neutral pH.
- the X-Gal in itself does not interact well with glass or metal electrodes.
- an electron mediator is needed to shuttle electrons to the electrode surface.
- One such mediator is a ferri/ferro cyanide (50/50) solution.
- a ferri/ferro cyanide solution can be used at about a 10 mM concentration when using an amperometric reaction and higher or lower concentrations for potentiometric reactions or increasing proportionately with the concentration of the added substrate.
- the voltage settings used in these experiments were 0 Volts (platinum electrode) and 0.5V for the chip.
- the Glucose Oxidase reaction scheme is shown on FIG. 4.
- the reaction takes place at about pH 7.5 in a buffer, such as 0.01M PBS buffer.
- the substrate was glucose and it is extremely soluble in water.
- the enzyme was regenerated with PMS (5-methyl-phenazinium methyl sulfate), which in turn utilizes the ferro/ferri cyanide shuttle for detection.
- the potential in this case had the platinum electrode set to 0V and the chip electrode set to 0.5V.
- results for beta-galactosidase immunoassay detection system are shown in FIG. 6.
- Microarray chips were electrochemically modified with a biotin-containing reagent. In one section of the chip represented by lanes 1-8, no biotin tag was placed. In lanes 9-16, biotinylated ⁇ -galactosidase was bound using a biotin-streptavidin-biotin complex. Redox reagents and substrates were added according to the reaction scheme in FIG. 3. These data show an amperometric response difference in the two parts of the chip, that is, lanes 1-8 versus lanes 9-16 containing ⁇ -galactosidase.
- FIG. 1-8 shows an amperometric response difference in the two parts of the chip, that is, lanes 1-8 versus lanes 9-16 containing ⁇ -galactosidase.
- FIG. 6 shows a 3D plot of the amperometric reaction with beta-galactosidase.
- the negative values on this plot indicate that ⁇ -galactosidase is bound.
- the neighboring electrodes are used as counter electrodes in the synthesis process and do not contain any affinity tags.
- FIG. 7 shows this chip profile as a slice (row) of the 3D plot shown in FIG. 6. Electrodes 9, 11, 13, and 15 contain beta-galactosidase.
- the glucose oxidase enzymatic reaction has some advantages and drawbacks relative to beta-galactosidase enzymatic reaction.
- the advantages are that all components of this reaction are extremely soluble in aqueous buffer.
- an electron mediator is required, such as PMS.
- PMS tends to “air oxidize” over time and must be made up freshly or stored under appropriate inert conditions or it will give a higher background signal.
- biotin was attached to glucose oxidase. The enzyme was then captured on the upper portion of the chip containing streptavidin (FIG. 9). As with ⁇ -galactosidase above, the chip contained biotin.
- Electrodes 1-8 contained a first affinity tag (e.g., biotin) and electrodes 9-16 contained a second affinity tag (e.g., streptavidin).
- the biotin complex allows the capture and detection of the enzyme system.
- FIG. 9 shows a slice of a 3D plot created for the capture and detection of glucose oxidase.
- the glucose oxidase specific affinity tags are located in lanes 1-8.
- HRP is a redox enzyme that catalyses the reduction of peroxide.
- the enzyme is small ( ⁇ 36 kD) and the enzyme turnover is large.
- peroxide may damage certain polymeric porous matrices or membranes.
- FIGS. 12 and 13 show amperometric detection of rabbit IgG bound to selected electrodes on a microarray biochip containing electrodes and a polyvinyl alcohol porous matrix (Combimatrix Corporation, Mukilteo, Wash.). HRP-tagged goat anti-Rb was used for the electrochemical detection.
- FIG. 13 shows detection of goat IgG bound to selected electrodes on a microarray biochip containing electrodes and a polyvinyl alcohol porous matrix (Combimatrix Corporation, Mukilteo, Wash.). HRP-tagged mouse monoclonal anti-goat antibody was used for the electrochemical detection. Samples are in S1 (1, 3, 5) and S2 (2, 4, 6). The sign of the current flow has been changed for presentation of these data. These data are in excellent agreement as to what would be expected based upon earlier work using fluorescent-tagged antibodies and standard fluorescence detection.
- FIG. 14 shows a 3D plot for oligonucleotide hybridization electrochemical detection.
- rabbit and Kras oligonucleotide sequences were in situ synthesized on an electrode containing mircoarray device.
- the Kras sequence used was TACGCCTCCA GCTCC [SEQ ID NO 1].
- the rabbit sequence used was AGGCTACGAA GACTT [SEQ ID NO 2]. Therefore, the oligonucleotide capture molecules synthesized by in situ electrochemistry techniques has a sequence of GGAGCTGGTG GCGTA [SEQ ID NO 3] for Kras known locations and a sequence of AAGTCTTCGT CGTAGCCT [SEQ ID NO 4] for rabbit known locations.
- the chip was set up in an alternating electrode-counter electrode format having a checkerboard pattern of sites having a Kras (or rabbit) oligonucleotide capture probe sequence surrounded diagonally by counter electrodes without oligonucleotides synthesized thereon.
- Target Kras sample (Operon) was treated to form single-stranded DNA and biotinylated with Kras complement (Operon) according to manufacturers instructions.
- Streptavidin conjugated HRP was added to the biotinylated Kras sequence complement to form a target complex or complementary Kras affinity-bound to HRP.
- the target Kras sample complexed with HRP was added to the chip and each electrode was measured for current (amps).
- microarray devices to have synthesized many different capture molecules at different known locations allows for multiple analyte detection on a single chip.
- the sample or samples to be investigated is labeled with an oxidation/reduction enzyme through standard conjugation means. Multiple samples can be pooled so that all of the targets to be investigated can be found from a single pooled sample.
- samples of AGP, ricin and rabbit mRNA samples were pooled and investigated on a single chip using laccase as the oxidation/reduction enzyme. Only those known locations having the appropriate capture molecules detected target even though the group of targets were either protein or nucleic acids.
- the limits of detection were found to be 5 pg/ml for AGP and 300 pg/ml for ricin that translates to 2.5 fM in a volume of 0.5 ml. Moreover, the dynamic detection range spanned four logs.
Abstract
Description
- This patent application is a continuation-in-part of U.S. patent application Ser. No. 09/944,727 filed Aug. 30, 2001.
- The present invention provides a process and an array for assaying for binding of target molecules to capture molecules on microarray devices, wherein the mircoarray devices contain electrodes. Specifically, the present invention provides a binding (including nucleotide hybridization) process to detect binding on a microarray wherein the microarray contains electronically addressable electrode devices. The inventive detection process further provides for an enzymatically catalyzed oxidation/reduction reaction to take place within a “virtual flask” region of a microarray wherein the reaction is detected by current changes detected on the addressable electrode.
- In the world of microarrays or biochips, biological molecules (e.g., oligonucleotides, polypeptides, oligopeptides and the like) are placed onto surfaces at defined locations for potential binding with target samples of nucleotides or receptors or other molecules. Microarrays are miniaturized arrays of biomolecules available or being developed on a variety of platforms. Much of the initial focus for these microarrays have been in genomics with an emphasis of single nucleotide polymorphisms (SNPs) and genomic DNA detection/validation, functional genomics and proteomics (Wilgenbus and Lichter,J. Mol. Med. 77:761, 1999; Ashfari et al., Cancer Res. 59:4759, 1999; Kurian et al., J. Pathol. 187:267, 1999; Hacia, Nature Genetics 21 suppl.:42, 1999; Hacia et al., Mol. Psychiatry 3:483, 1998; and Johnson, Curr. Biol. 26:R171, 1998).
- There are, in general, three categories of microarrays (also called “biochips” and “DNA Arrays” and “Gene Chips” but this descriptive name has been attempted to be a trademark) having oligonucleotide content. Most often, the oligonucleotide microarrays have a solid surface, usually silicon-based and most often a glass microscopic slide. Oligonucleotide microarrays are often made by different techniques, including (1) “spotting” by depositing single nucleotides for in situ synthesis or completed oligonucleotides by physical means (ink jet printing and the like), (2) photolithographic techniques for in situ oligonucleotide synthesis (see, for example, Fodor U.S. Pat. No. 5,445,934 and the additional patents that claim priority from this priority document, (3) electrochemical in situ synthesis based upon pH based removal of blocking chemical functional groups (see, for example, Montgomery U.S. Pat. No. 6,093,302 the disclosure of which is incorporated by reference herein and Southern, U.S. Pat. No. 5,667,667), and (4) electric field attraction/repulsion of fully-formed oligonucleotides (see, for example, Hollis et al., U.S. Pat. No. 5,653,939 and its duplicate Heller U.S. Pat. No. 5,929,208). Only the first three basic techniques can form oligonucleotides in situ that are, building each oligonucleotide, nucleotide-by-nucleotide, on the microarray surface without placing or attracting fully formed oligonucleotides.
- With regard to placing fully-formed oligonucleotides at specific locations, various micro-spotting techniques using computer-controlled plotters or even ink-jet printers have been developed to spot oligonucleotides at defined locations. One techniques loads glass fibers having multiple capillaries drilled through then with different oligonucleotides loaded into each capillary tube. Microarray chips, often simply glass microscope slides, are then stamped out much like a rubber stamp on each sheet of paper of glass slide. It is also possible to use “spotting” techniques to build oligonucleotides in situ. Essentially, this involves “spotting” relevant single nucleotides at the exact location or region on a slide (preferably a glass slide) where a particular sequence of oligonucleotide is to be built. Therefore, irrespective of whether or not fully formed oligonucleotides or single nucleotides are added for in situ synthesis, spotting techniques involve the precise placement of materials at specific sites or regions using automated techniques.
- Another technique involves a photolithography process involving photomasks to build oligonucleotides in situ, base-by-base, by providing a series of precise photomasks coordinated with single nucleotide bases having light-cleavable blocking groups. This technique is described in Fodor et al. U.S. Pat. No. 5,445,934 and it's various progeny patents. Essentially, this technique provides for “solid-phase chemistry, photolabile protecting groups, and photolithography . . . to achieve light-directed spatially-addressable parallel chemical synthesis.” Binary masks are used in the preferred embodiment
- The electrochemistry platform (Montgomery U.S. Pat. No. 6,093,302, the disclosure of which is incorporated by reference herein) provides a microarray based upon a semiconductor chip platform having a plurality of microelectrodes. This chip design uses Complimentary Metal Oxide Semiconductor (CMOS) technology to create high-density arrays of microelectrodes with parallel addressing for selecting and controlling individual microelectrodes within the array. The electrodes turned on with current flow generate electrochemical reagents (particularly acidic protons) to alter the pH in a small and defined “virtual flask” region or volume adjacent to the electrode. The microarray is coated with a porous matrix for a reaction layer material. Thickness and porosity of the material is carefully controlled and biomolecules are synthesized within volumes of the porous matrix whose pH has been altered through controlled diffusion of protons generated electrochemically and whose diffusion is limited by diffusion coefficients and the buffering capacities of solutions.
- The microarray systems have detection processes generally using some form of photon-based detection. That is, most detection processes use fluorescent probes (alternatively visible dyes or luminescent probes) attached to “target” DNA sequences to detect binding or hybridization to an oligonucleotide capture probe attached on a microarray. Depending upon the intensity of the signal, such microarrays having probes to show hybridization have to be read through laser confocal microscope-based system for microarrays configured in a monolayer (such as those microarrays made through high density spotting or photolithography techniques) or by a video-type camera (such as a CCD camera) for those microarrays having a three-dimensional matrix for each spot in high density formats. In each instance, there is often stray light or other noise signals that cause false readings to be made. Moreover, it occasionally becomes difficult to distinguish between shades of gray or barely perceptible signals as true positives or false positives. Therefore, there is a need in the art for improvements to the detection/reading process for analyzing microarrays. The present invention was made to address this need and to provide a detection system that can generate a more objective “yes” or “no” answer for each site in high-density microarray detection.
- The present invention provides a process for reading microarray devices having addressable electrodes to determine binding between a capture probe and a target molecule, comprising:
- (a) providing an array having a plurality of electrodes and a plurality of capture molecules at sites corresponding to the electrodes;
- (b) non-specifically attaching an oxidation/reduction enzyme moiety to one or a plurality of target molecules in a sample for analysis to create a prepped target sample;
- (c) administering the prepped target sample to the array and allowing for binding of target molecules to capture molecules;
- (d) adding a substrate to the array that will create a local voltage signal when catalyzed by the oxidation/reduction enzyme through local generation of electrochemical reagents; and
- (e) measuring for the presence or absence of a voltage or current signal generated locally by electrochemical reagents at each electrode having a capture molecule attached thereto.
- Preferably, the array having a plurality of electrodes and capture molecules corresponding to the electrodes is generated by a technique selected from the group consisting of in situ synthesis with electrochemical techniques, spotting the capture molecules, ink-jet printing the capture molecules, and in situ synthesis through photolighography techniques. Most preferably, the array having a plurality of electrodes and capture molecules corresponding to the electrodes is formed by in situ synthesis with electrochemical techniques. Preferably, the oxidation/reduction enzyme is selected from the group consisting of laccase, horseradish peroxidase, β-galactosidase, glucose oxidase, alkaline phosphatase, dehydrogenases, and combinations thereof. Preferably, the oxidation/reduction enzyme is attached to the target molecule(s) through an antibody and anti-idiotype antibody combination or through a biotin and streptavidin (or avidin) binding combination. Preferably, the array having a plurality of electrodes further comprises a porous reaction layer covering the electrodes, wherein the porous reaction layer has a thickness of from about 0.1 microns to about 10 microns and whereby the porous reaction layer functions to block diffusion of oxidation/reduction activity products such that there is little lateral signal being picked up at an adjacent electrode. Most preferably, the porous reaction layer is made from a polymeric material selected from the group consisting of polyvinyl alcohol, polyvinyl acetate, dextran, complex polysaccharides, epoxy-based polymers, tricellulose acetate, polyurethane, agarose, controlled porosity glass with a PTFE resin, and combinations thereof. Preferably, the capture molecule is a molecule from the class of molecules selected from the group consisting of oligonucleotides, polypeptides, antibodies, glycosylated polypeptides, polysaccharides, and mixed molecules having monomers from a plurality of the foregoing molecules. Similarly, the target molecule is one likely to bind to at least one of a plurality of capture molecules. Most preferably, a target molecule is from a class of molecules selected from the group consisting of DNA, RNA, single-stranded DNA, ribosomal RNA, mitochondrial DNA, cellular receptors (i.e., glycosylated or non-glycosylated membrane-bound proteins), polypeptides, glycosylated polypeptides, antibodies, cellular antigenic determinants, organic molecules, metal ions, salt anions and cations, and combinations thereof.
- The present invention further provides a mircoarray device for detecting binding of a target molecule to a capture probe, comprising:
- (a) an array having a plurality of electrodes and a plurality of capture molecules at sites corresponding to the electrodes;
- (b) an oxidation/reduction enzymatic moiety bound to one or a plurality of target molecules in a sample for analysis, wherein the oxidation/reduction enzymatic moiety bound to the target molecules is incubated with the capture molecules on the array such that binding between capture molecules and target molecules that bind, will occur;
- (c) a substrate molecule that will create a local voltage signal when catalyzed by the oxidation/reduction enzyme through local generation of electrochemical reagents; and
- (e) a voltage signal measuring device electrically connected to each electrode on the array.
- Preferably, the array having a plurality of electrodes and capture molecules corresponding to the electrodes is generated by a technique selected from the group consisting of in situ synthesis with electrochemical techniques, spotting the capture molecules, ink-jet printing the capture molecules, and in situ synthesis through photolighography techniques. Most preferably, the array having a plurality of electrodes and capture molecules corresponding to the electrodes is formed by in situ synthesis with electrochemical techniques. Preferably, the oxidation/reduction enzyme is selected from the group consisting of laccase, horseradish peroxidase, β-galactosidase, glucose oxidase, alkaline phosphatase, dehydrogenases, and combinations thereof. Preferably, the oxidation/reduction enzyme is attached to the target molecule(s) through an antibody and anti-idiotype antibody combination or through a biotin and streptavidin (or avidin) binding combination. Preferably, the array having a plurality of electrodes further comprises a porous reaction layer covering the electrodes, wherein the porous reaction layer has a thickness of from about 0.1 microns to about 10 microns and whereby the porous reaction layer functions to block diffusion of oxidation/reduction activity products such that there is little lateral signal being picked up at an adjacent electrode. Most preferably, the porous reaction layer is made from a polymeric material selected from the group consisting of polyvinyl alcohol, polyvinyl acetate, polyvinyl alcohol, tricellulose acetate, complex polysaccharides, polyurethane, agarose, controlled porosity glass with a PTFE resin, dextran, epoxy-based polymers, and combinations thereof. Preferably, the capture molecule is a molecule from the class of molecules selected from the group consisting of oligonucleotides, polypeptides, antibodies, glycosylated polypeptides, polysaccharides, and mixed molecules having monomers from a plurality of the foregoing molecules. Similarly, the target molecule is one likely to bind to at least one of a plurality of capture molecules. Most preferably, a target molecule is from a class of molecules selected from the group consisting of DNA, RNA, single-stranded DNA, ribosomal RNA, mitochondrial DNA, cellular receptors (i.e., glycosylated or non-glycosylated membrane-bound proteins), polypeptides, glycosylated polypeptides, antibodies, cellular antigenic determinants, organic molecules, metal ions, salt anions and cations, and combinations thereof.
- FIG. 1 shows the chemical reaction scheme when using horseradish peroxidase (HRP) as the oxidation/reduction enzyme. Specifically, the targeted molecule is AGP (α-1 acid glycoprotein) that has been complexed with HRP by adding a biotin-labeled antibody specific for an epitope of AGP. The target molecule is complexed with HRP by adding an avidin-labeled HRP enzyme. The mircoarray site used for detecting AGP as the target molecule has another antibody binding to a different epitope on AGP as the capture molecule. Moreover, the first antibody (labeled “Ab1”) is self-assembled to an oligonucleotide mircoarray through a tag array capture probe.
- FIG. 2 shows a similar configuration for detecting AGP as a known site on a mircoarray, except this complex uses the multimeric nature of streptavidin to capture both biotin-labeled second antibody bound to a second epitope on AGP and biotin-labeled different oxidation/reduction enzyme laccase.
- FIG. 3 shows the chemistry of the oxidation/reduction reaction when β-galactosidase is the oxidation/reduction enzyme and X-Gal (5-bromo-4-chloro-3-indoyl-β-D-ganactopyranoside) is the substrate. The reaction forms indigo blue and generates electrochemical reactants. Preferably, the reaction is carried out at about pH 7.0 in 0.01 M phosphate buffer (PBS) with 1 mM Fe2+/Fe3+. The X-Gal should be present in saturation amounts.
- FIG. 4 shows the chemical reaction scheme when using glucose oxidase as the enzyme for oxidation reduction. Electrochemical reagents are generated with PMS (5-methyl-phenazinium methyl sulfate) as the substrate.
- FIG. 5 shows a reaction scheme with HRP (horse radish peroxidase) as the oxidation/reduction enzyme and catechol as the substrate.
- FIG. 6 shows a 3D plot of the amperometric measurement of β-galactosidase in an immunoassay detection system. Microarray chips were electrochemically modified with a biotin-containing reagent. In one section of the chip represented by lanes 1-8, no biotin tag was placed. In lanes 9-16, biotinylated β-galactosidase was bound using a biotin-streptavidin-biotin complex. Redox reagents and substrates were added according to the reaction scheme in FIG. 3. These data show an amperometric response difference in the two parts of the chip, that is, lanes 1-8 versus lanes 9-16 containing β-galactosidase.
- FIG. 7 shows a chip profile plot taken from a slice or row of the 3D plot from FIG. 6, wherein
electrodes spots - FIG. 8 shows binding and detection of a fluorescein-labeled β-galactosidase using an amperometric technique showing redox detection results. The fluorescein acted as a low molecular weight antigen attached to the larger enzyme. The oxidation/reduction enzyme capture was made possible by placement of an affinity-tagged anti-fluorescein antibody on alternating electrodes in row S2. These data show that those known locations associated with electrodes having fluorescein-labeled β-galactosidase showed enhanced signals. Moreover, these data were verified using epi-fluorescent microscopy to confirm the electrochemical results.
- FIG. 9 shows a slice of a 3D plot created for the capture and detection of glucose oxidase as the oxidation/reduction enzyme. The glucose oxidase specific affinity tags are located in lanes 1-8. The glucose oxidase systems had higher background signals than other oxidation/reduction enzymes.
- FIG. 10 shows a plot of a voltage versus current display for HRP (horse radish peroxidase) as a redox curve monitored by a single 100 micron diameter electrode on a bare (i.e., no in situ synthesis of biomolecules) mircoarray chip. The cyclic voltamogram-like results indicate at a negative potential and the amperometric difference (with and without enzyme) was substantial.
- FIG. 11 shows the data from FIG. 10 in an amperometric experiment performed over a time course in a plot of current versus time for the peroxidase reaction. It should be noted that the current flow levels off after a period of a few minutes.
- FIG. 12 shows an amperometric 3D plot and visualized image for antibodies against AGP, Phage, BV (bacilovirus) spores, and RCA bound to electrodes through oligos P-5, P-6, P-7 and P-8, respectively. FTIC was bound to electrodes through oligo P-1. Corresponding antigens were detected by a complex of corresponding secondary antibodies conjugated with HRP. ODP/H2O2 was used as the enzyme substrate.
- FIG. 13 shows a similar plot of goat IgG bound to electrodes S1 (1, 3 and 5) and S2 (2, 4 and 6) through oligonucleotide tagging. Detection of goat IgG was made by a complex of mouse anti-goat monoclonal antibody conjugated with HRP. FIG. 13 reverses the sign of current flow for better visualization.
- FIG. 14 shows a 3D plot for oligonucleotide hybridization electrochemical detection. Specifically,
oligo 6 andoligo 5 oligonucleotide sequences were in situ synthesized on an electrode containing mircoarray device. The chip was set up in an alternating electrode-counter electrode format having a checkerboard pattern of sites having anoligo 6 oroligo 5 oligonucleotide capture probe sequence surrounded diagonally by counter electrodes without oligonucleotides synthesized thereon. Target oligo5/6 sample (Operon) was treated to form single-stranded DNA (Operon) and biotinylated with oligo complement (Operon) according to manufacturers instructions. Streptavidin conjugated with HRP (Sigma) was added to thebiotinylated oligo 5/6 sequence complement to form a target complex orcomplementary oligo 5/6 affinity-bound to HRP. Thetarget oligo 5/6 sample, complexed with HRP, was added to the chip and each electrode was measured for current (amps). These data are shown in FIG. 14 in the top panel in a 3D plat and in the bottom panel showing a positive signal in a checkerboard foroligo 6 andoligo 5 oligonucleotide capture probes and the bottom panel showing no signal for rabbit sequence captures probes. OPD (orthophenylamine diamine) was used as the HRP substrate. - FIG. 15 shows the detection of Rab-biotin at a 100 pM concentration versus a silver/silver chloride reference electrode. Detection was measured with electrical potential (rather than current). The microarray used was coated with a PVA (polyvinyl acetate) porous matrix and OPD/H2O2 was used as the enzymatic substrate.
- FIG. 16 shows calibration curves for detecting AGP (left) and RCA (right). The log plots show the extreme sensitivity of the inventive process.
- FIG. 17 shows the dependence of the amperometric signal on a log concentration of a Rab-biotin oligonucleotide on electrode-containing microarray devices coated with a poly-dextran porous matrix. The incubation time was 2 hours at 40° C. incubation temperature.
- There is disclosed a process for reading microarray devices having addressable electrodes to determine binding between a capture probe and a target molecule, comprising:
- (a) providing an array having a plurality of electrodes and a plurality of capture molecules at sites corresponding to the electrodes;
- (b) non-specifically attaching an oxidation/reduction enzymatic moiety to one or a plurality of target molecules in a sample for analysis to create a prepped target sample;
- (c) administering the prepped target sample to the array and allowing for binding of target molecules to capture molecules;
- (d) adding a substrate to the array that will create a local voltage signal when catalyzed by the oxidation/reduction enzyme through local generation of electrochemical reagents; and
- (e) measuring for the presence or absence of a voltage signal generated locally by electrochemical reagents at each electrode having a capture molecule attached thereto.
- Electrode-Based Microarrays
- Electrode-based microarrays can be made with various oligomers attached to predefined regions, wherein each predefined region is defined by the presence of an addressable electrode. An addressable electrode is one where it can be electronically accessed to create a current or voltage. Electrode-based microarrays further and often comprise a porous matrix layer that holds the capture molecules and provides a three dimensional virtual flask (cylindrical in the case of a circular electrode). In a preferred embodiment, the porous matrix layer is a membrane, wherein the membrane material is selected from the group consisting of polyvinyl alcohol, polyvinyl acetate, polyvinyl alcohol, tricellulose acetate, polyurethane, agarose, controlled porosity glass with a PTFE resin, and combinations thereof. In each case, the microarray, contains a plurality (on in rare cases only one) of capture molecules. In the most common form of microarray, the capture molecules are oligonucleotides than can bind to complementary sequence regions (or nearly complementary sequence regions depending upon the hybridization conditions) of DNA or mRNA from the target samples. The challenge next becomes how one can detect this binding event or hybridization event. In terms of marketed products, that are generally made by spotting or ink-jet printing oligonucleotides onto planar, non-porous surfaces such as glass slides, there are sample labeling kits commercially available that cause the sample nucleic acid to become labeled with a fluorescent dye. Often it is a fluorescent dye sold under the trademarks of Texas Red®, or Cy® Dyes Cy3 and Cy5. The microarray is “read” through a common fluorometer arrangement with either microscopic magnification or imaging stitching and looking for fluorescence at the known locations where the capture molecule was spotted or synthesized. This common technique of fluorescent detection of microarrays using a standard fluorometer configuration with a microarray is the detection method universally used. However, there are optics issues, difficulty in labeling with fluorescent dyes, occasional high background problems and most importantly, extremely high costs associated with fluorescent microscopic equipment. Therefore, there is a need to detect molecular binding on microarrays using lower cost equipment. The present inventive method uses electrochemical reagents generated locally within a porous reaction layer or membrane to only locally provide current or voltage to a nearby electrode, whose current or voltage signal can be detected at the nearby electrode and not “cross-talk” onto neighboring electrodes.
- Immunoassays
- Immunoassays are based generally upon antibody binding to another molecule, generally a protein sugar or glycoprotein. The problems of immunoassays are generally detection of this binding event. The sandwich based immunoassays are based upon the fact that one antibody has already been attached to the surface of the chip (the capture antibody; most often a monoclonal). The analyte is then bound to the antibody and a second antibody (usually polyclonal) is added for use as a reporter group. The second reporter antibody will generally contain a fluorophore or have an enzyme covalently attached. Alternatively, the reporter antibody may contain a biotin molecule. To this biotin molecule, a streptavidin-enzyme conjugate can be an attached. Therefore, the inventive process can be constructed with immunoassays, even sandwich-type immunoassays by providing for the oxidation/reduction enzyme to be attached to a complex formed when binding to a capture molecule (i.e., first antibody) occurs. The latter assay formats allows a host of generic assay format to be designed without performing the grueling task of providing (synthesizing) analyte-based individual antibody-enzyme conjugates. Examples of immunoassays in a sandwich configuration are shown in FIGS. 1 and 2.
- Oxidation/Reduction Enzyme Systems
- Four different oxidation/reduction enzyme systems are exemplified herein. Each has different potential settings, each function in a unique pH range, they may require redox mediators and lastly, the substrate conditions vary. Reactions schemes are provided for each system.
- The HRP (horse radish peroxidase) reaction scheme with catechol as the substrate is shown in FIG. 5. Other HRP substrates include, for example, OPD (orthophenylene diamine), aminophenols and aromatic polyamines.
- Catechol+H2O2→Quinone+H2O
- Quinone+2H++2e→Catechol.
- In a first assay, the product (quinone) was detected amperometrically. The first assay was performed at −0.3 V versus Pt wire in 0.05 M Na-citrate-phosphate buffer pH 5.0 containing 0.2 M Na2SO4. Catechol and hydrogen peroxide in 1 mM concentration were used as an enzymatic substrate. A proper checkerboard pattern from the microarray showed that binding occurred at the proper locations without the presence of noise or cross talk bleeding over to neighboring electrode locations.
- A second assay was performed at −0.3 V vs. Pt wire in 0.05 M Na-citrate-phosphate buffer pH 5.0 containing 0.2 M Na2SO4. Catechol in 1 mM concentration was used as an enzymatic substrate. This reaction scheme also produced the expected binding results and followed the reaction scheme as follows:
- Catechol+O2→Quinone+H2O
- The product (quinone) was detected amperometrically:
- Quinone+2H++2e→Catechol.
- β-Galactosidase reaction cleaves penultimate β-galactose residues from oligosaccharides or from glycosyl derivatives. The reaction scheme is shown in FIG. 3. The substrate used was X-Gal, which is an indolyl derivative of β-galactopyranoside. Biotinylated β-galactosidase was purchased for studies. The reactions were carried out at pH 7.0 in PBS buffer, 0.01 M. A given quantity of X-Gal was dissolved in DMF (very soluble) so that when it was added to the aqueous buffer, a substrate concentration of about 0.1 mM was achieved (saturation). The X-Gal/DMF solution was added while vigorously vortexing the aqueous phase because of the limited solubility of the X-Gal water. If the DMF/X-Gal solution is added without vigorous vortexing, the X-Gal would precipitate from solution. The instability of this solution requires that a fresh solution needs to be prepared daily.
- Alternatively, an organic substrate (such as catechol) can be used. The turnover rate for this enzyme is lower than that for other redox enzymes, but the enzyme is very stable at neutral pH.
- The X-Gal in itself does not interact well with glass or metal electrodes. Thus, an electron mediator is needed to shuttle electrons to the electrode surface. One such mediator is a ferri/ferro cyanide (50/50) solution. For example, a ferri/ferro cyanide solution can be used at about a 10 mM concentration when using an amperometric reaction and higher or lower concentrations for potentiometric reactions or increasing proportionately with the concentration of the added substrate. The voltage settings used in these experiments were 0 Volts (platinum electrode) and 0.5V for the chip.
- The Glucose Oxidase reaction scheme is shown on FIG. 4. Preferably, the reaction takes place at about pH 7.5 in a buffer, such as 0.01M PBS buffer. The substrate was glucose and it is extremely soluble in water. The enzyme was regenerated with PMS (5-methyl-phenazinium methyl sulfate), which in turn utilizes the ferro/ferri cyanide shuttle for detection. The potential in this case had the platinum electrode set to 0V and the chip electrode set to 0.5V.
- β-Galactosidase Results
- Results for beta-galactosidase immunoassay detection system are shown in FIG. 6. Microarray chips were electrochemically modified with a biotin-containing reagent. In one section of the chip represented by lanes 1-8, no biotin tag was placed. In lanes 9-16, biotinylated β-galactosidase was bound using a biotin-streptavidin-biotin complex. Redox reagents and substrates were added according to the reaction scheme in FIG. 3. These data show an amperometric response difference in the two parts of the chip, that is, lanes 1-8 versus lanes 9-16 containing β-galactosidase. FIG. 6 shows a 3D plot of the amperometric reaction with beta-galactosidase. The negative values on this plot indicate that β-galactosidase is bound. The neighboring electrodes are used as counter electrodes in the synthesis process and do not contain any affinity tags. Similarly, FIG. 7 shows this chip profile as a slice (row) of the 3D plot shown in FIG. 6.
Electrodes - In yet another reaction and immunochemical detection, a capture and detection of fluorescein-containing beta-galactosidase was performed. An anti-fluorescein antibody containing an affinity tag was captured in row two of a biochip made by an in situ synthesis electrochemical process (Combimatrix Corporation, Mukilteo, Wash.). The fluorescein acted as a low molecular weight antigen attached to the larger enzyme. The redox detection results are shown in FIG. 8. The electrode sites containing the F-β-galactosidase showed an enhanced value. The binding of F-β-galactosidase to the membrane above the respective electrodes was corroborated and confirmed using the epi-fluorescent microscope. These data exactly track the results obtained with the inventive process of detecting current flow at the electrode. In FIG. 8, capture was made possible by the placement of an affinity tagged anti-F antibody on alternate electrodes in row S2.
- Glucose-Oxidase Electrochemical Detection
- The glucose oxidase enzymatic reaction has some advantages and drawbacks relative to beta-galactosidase enzymatic reaction. The advantages are that all components of this reaction are extremely soluble in aqueous buffer. However, an electron mediator is required, such as PMS. PMS tends to “air oxidize” over time and must be made up freshly or stored under appropriate inert conditions or it will give a higher background signal. In an example of an assay performed with glucose oxidase, biotin was attached to glucose oxidase. The enzyme was then captured on the upper portion of the chip containing streptavidin (FIG. 9). As with β-galactosidase above, the chip contained biotin. Electrodes 1-8 contained a first affinity tag (e.g., biotin) and electrodes 9-16 contained a second affinity tag (e.g., streptavidin). The biotin complex allows the capture and detection of the enzyme system. FIG. 9 shows a slice of a 3D plot created for the capture and detection of glucose oxidase. The glucose oxidase specific affinity tags are located in lanes 1-8.
- Horse Radish Peroxidase Detection
-
- The redox curve for the peroxidase reaction was monitored by a single 100 micron diameter electrode on a bare (i.e., no porous membrane or capture molecules synthesized thereon) electrode-containing microarray device and is shown in FIG. 10. The cyclic voltamogram like results indicate at a negative potential, the amperometric difference with and without HRP enzyme was substantial. Taking these data, an amperometric experiment was performed over a period of time (FIG. 11). It should be noted that the current flow leveled off after a period of time. Thus, the best time to begin these studies after about 2 minutes (FIG. 11).
- For the peroxidase system, we have undertaken some initial experiments involving immunoassays. Rabbit IgG or goat IgG were affinity tagged and bound to the upper section and lower section of the membrane, respectively. Detection was made possible using HRP-tagged goat anti-rabbit Ab or HRP-tagged mouse monoclonal anti-goat antibodies. The results of these experiments are shown in FIGS. 12 and 13. Specifically, FIG. 12 shows amperometric detection of rabbit IgG bound to selected electrodes on a microarray biochip containing electrodes and a polyvinyl alcohol porous matrix (Combimatrix Corporation, Mukilteo, Wash.). HRP-tagged goat anti-Rb was used for the electrochemical detection. Samples are in S4 (1, 3, 5) and S5 (2, 4). The sign of the current flow has been changed for presentation of these data. Further, FIG. 13 shows detection of goat IgG bound to selected electrodes on a microarray biochip containing electrodes and a polyvinyl alcohol porous matrix (Combimatrix Corporation, Mukilteo, Wash.). HRP-tagged mouse monoclonal anti-goat antibody was used for the electrochemical detection. Samples are in S1 (1, 3, 5) and S2 (2, 4, 6). The sign of the current flow has been changed for presentation of these data. These data are in excellent agreement as to what would be expected based upon earlier work using fluorescent-tagged antibodies and standard fluorescence detection.
- Oligonucleotide Capture
- FIG. 14 shows a 3D plot for oligonucleotide hybridization electrochemical detection. Specifically, rabbit and Kras oligonucleotide sequences were in situ synthesized on an electrode containing mircoarray device. The Kras sequence used was TACGCCTCCA GCTCC [SEQ ID NO 1]. The rabbit sequence used was AGGCTACGAA GACTT [SEQ ID NO 2]. Therefore, the oligonucleotide capture molecules synthesized by in situ electrochemistry techniques has a sequence of GGAGCTGGTG GCGTA [SEQ ID NO 3] for Kras known locations and a sequence of AAGTCTTCGT CGTAGCCT [SEQ ID NO 4] for rabbit known locations.
- The chip was set up in an alternating electrode-counter electrode format having a checkerboard pattern of sites having a Kras (or rabbit) oligonucleotide capture probe sequence surrounded diagonally by counter electrodes without oligonucleotides synthesized thereon. Target Kras sample (Operon) was treated to form single-stranded DNA and biotinylated with Kras complement (Operon) according to manufacturers instructions. Streptavidin conjugated HRP was added to the biotinylated Kras sequence complement to form a target complex or complementary Kras affinity-bound to HRP. The target Kras sample complexed with HRP was added to the chip and each electrode was measured for current (amps). These data are shown in FIG. 14 in the top panel in a 3D plat and in the bottom panel showing a positive signal in a checkerboard pattern for Kras oligonucleotide capture probes and the bottom panel showing no signal for rabbit sequence capture probes.
- Multiple Analyte Detection
- The ability of microarray devices to have synthesized many different capture molecules at different known locations allows for multiple analyte detection on a single chip. In each case the sample or samples to be investigated is labeled with an oxidation/reduction enzyme through standard conjugation means. Multiple samples can be pooled so that all of the targets to be investigated can be found from a single pooled sample. In one experiment, samples of AGP, ricin and rabbit mRNA samples were pooled and investigated on a single chip using laccase as the oxidation/reduction enzyme. Only those known locations having the appropriate capture molecules detected target even though the group of targets were either protein or nucleic acids. Based upon multiple microarray investigations, the limits of detection were found to be 5 pg/ml for AGP and 300 pg/ml for ricin that translates to 2.5 fM in a volume of 0.5 ml. Moreover, the dynamic detection range spanned four logs.
-
1 4 1 15 DNA Artificial Sequence KRAS 1 tacgcctcca gctcc 152 15 DNA Artificial Sequence rabbit fragment 2 aggctacgaa gactt 15 3 15 DNA Artificial Sequence microarray capture probe 3 ggagctggtg gcgta 15 4 18 DNA Artificial Sequence microarray capture probe 4 aagtcttcgt cgtagcct 18
Claims (18)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/229,755 US20030082601A1 (en) | 2001-08-30 | 2002-08-27 | Enzyme-amplified redox microarray detection process |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/944,727 US10539561B1 (en) | 2001-08-30 | 2001-08-30 | Enzyme-amplified redox microarray detection process |
US10/229,755 US20030082601A1 (en) | 2001-08-30 | 2002-08-27 | Enzyme-amplified redox microarray detection process |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/944,727 Continuation-In-Part US10539561B1 (en) | 2001-08-30 | 2001-08-30 | Enzyme-amplified redox microarray detection process |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030082601A1 true US20030082601A1 (en) | 2003-05-01 |
Family
ID=25481957
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/944,727 Expired - Fee Related US10539561B1 (en) | 2001-08-30 | 2001-08-30 | Enzyme-amplified redox microarray detection process |
US10/229,755 Abandoned US20030082601A1 (en) | 2001-08-30 | 2002-08-27 | Enzyme-amplified redox microarray detection process |
US16/689,473 Abandoned US20200072823A1 (en) | 2001-08-30 | 2019-11-20 | Enzyme-Amplified Redox Micoarray Detection Process |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/944,727 Expired - Fee Related US10539561B1 (en) | 2001-08-30 | 2001-08-30 | Enzyme-amplified redox microarray detection process |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/689,473 Abandoned US20200072823A1 (en) | 2001-08-30 | 2019-11-20 | Enzyme-Amplified Redox Micoarray Detection Process |
Country Status (4)
Country | Link |
---|---|
US (3) | US10539561B1 (en) |
EP (1) | EP1430154B1 (en) |
AU (1) | AU2002341612A1 (en) |
WO (1) | WO2003019147A2 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030152930A1 (en) * | 2002-02-11 | 2003-08-14 | Matsushita Electric Industrial Co., Ltd. | Method and apparatus for detecting DNA hybridization |
US20050170405A1 (en) * | 2004-02-03 | 2005-08-04 | Canon Kabushiki Kaisha | Sensor and detecting method |
WO2005106034A1 (en) | 2004-04-29 | 2005-11-10 | Agency For Science, Technology And Research | Method and device for detection of nucleic acids and/or polypeptides |
US20070072169A1 (en) * | 2005-09-29 | 2007-03-29 | Combimatrix Corporation | Process and apparatus for measuring binding events on a microarray of electrodes |
DE102006051482A1 (en) * | 2006-07-31 | 2008-02-14 | Nikolaus Bartels | Arrangement for detecting substances, manufacturing the arrangement and its use |
US20090036324A1 (en) * | 2007-07-16 | 2009-02-05 | Rong Fan | Arrays, substrates, devices, methods and systems for detecting target molecules |
WO2009126828A3 (en) * | 2008-04-09 | 2010-03-04 | California Institute Of Technology | Capture agents and related methods and systems for detecting and/or sorting targets |
US20100167308A1 (en) * | 2003-09-10 | 2010-07-01 | Abbott Point Of Care Inc. | Method for measuring an analyte in blood |
US20110039717A1 (en) * | 2006-08-02 | 2011-02-17 | Kwong Gabriel A | Methods and systems for detecting and/or sorting targets |
US20110166034A1 (en) * | 2006-08-02 | 2011-07-07 | Kwong Gabriel A | Capture agents and related methods and systems for detecting and/or sorting targets |
US10983116B2 (en) | 2012-08-24 | 2021-04-20 | Yale University | System, device and method for high-throughput multi-plexed detection |
US11066689B2 (en) | 2014-12-03 | 2021-07-20 | IsoPlexis Corporation | Analysis and screening of cell secretion profiles |
US11353448B2 (en) | 2015-02-13 | 2022-06-07 | California Institute Of Technology | Methods and compositions for quantifying metabolites and proteins from single cells |
US11493508B2 (en) | 2016-11-11 | 2022-11-08 | IsoPlexis Corporation | Compositions and methods for the simultaneous genomic, transcriptomic and proteomic analysis of single cells |
US11525783B2 (en) | 2016-11-22 | 2022-12-13 | IsoPlexis Corporation | Systems, devices and methods for cell capture and methods of manufacture thereof |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100396791C (en) * | 2004-09-17 | 2008-06-25 | 北京大学 | Method for detecting oligomeric nucleotide through intercalating dye fluorescent resonant energy transfer molecule |
US20070231794A1 (en) * | 2005-09-21 | 2007-10-04 | Combimatrix Corporation | Process to detect binding events on an electrode microarray using enzymes |
US7820394B2 (en) * | 2005-12-02 | 2010-10-26 | Catassays | Ultrasensitive bioanalytical assays based on the use of high-gain catalytic chemical amplification |
CN101241097B (en) * | 2007-09-18 | 2011-08-03 | 中国科学院上海应用物理研究所 | Electrochemical DNA detection method adopting stem-loop structure for detecting probe, and reagent kit thereof |
CN102183645B (en) * | 2011-01-24 | 2013-12-11 | 中国科学院合肥物质科学研究院 | Food-borne pathogenic bacteria detection immuno-sensor and preparation method thereof |
WO2022082098A1 (en) * | 2020-10-16 | 2022-04-21 | Lmx Medtech Llc | Oxidative mass labeling |
JP2024502865A (en) * | 2021-01-13 | 2024-01-23 | ソレント・セラピューティクス・インコーポレイテッド | Methods, assays and systems for detecting target analytes |
DE102022000897A1 (en) | 2022-03-15 | 2023-09-21 | Ruhr-Universität Bochum, Körperschaft des öffentlichen Rechts | Implantable biosensor |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5122244A (en) * | 1990-02-03 | 1992-06-16 | Boehringer Mannheim Gmbh | Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor |
US5200051A (en) * | 1988-11-14 | 1993-04-06 | I-Stat Corporation | Wholly microfabricated biosensors and process for the manufacture and use thereof |
US5632957A (en) * | 1993-11-01 | 1997-05-27 | Nanogen | Molecular biological diagnostic systems including electrodes |
US5679535A (en) * | 1992-03-05 | 1997-10-21 | University Collge Dublin | Apparatus, kit and method for the collection and determination of environmental antigens |
US5807999A (en) * | 1993-02-01 | 1998-09-15 | Mt. Sinai School Of Medicine Of The City University Of New York | Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone H1 and uses therefor |
US5865972A (en) * | 1995-12-19 | 1999-02-02 | Universite De Geneve | Integrated electrochemical microsensors and microsystems for direct reliable chemical analysis of compounds in complex aqueous solutions |
US5948624A (en) * | 1994-05-11 | 1999-09-07 | Rothschild; Kenneth J. | Methods for the detection and isolation of biomolecules |
US6051380A (en) * | 1993-11-01 | 2000-04-18 | Nanogen, Inc. | Methods and procedures for molecular biological analysis and diagnostics |
US6090589A (en) * | 1990-12-31 | 2000-07-18 | Promega Corporation | Nucleic acid amplification with DNA-dependent RNA polymerase activity of RNA replicases |
US6093302A (en) * | 1998-01-05 | 2000-07-25 | Combimatrix Corporation | Electrochemical solid phase synthesis |
US6100045A (en) * | 1997-02-10 | 2000-08-08 | Dsm N.V. | Detection of analytes using electrochemistry |
US6303082B1 (en) * | 1999-12-15 | 2001-10-16 | Nanogen, Inc. | Permeation layer attachment chemistry and method |
US20020081588A1 (en) * | 1998-06-24 | 2002-06-27 | Therasense, Inc. | Multi-sensor array for electrochemical recognition of nucleotide sequences and methods |
US6576461B2 (en) * | 1998-08-24 | 2003-06-10 | Therasense, Inc. | Electrochemical affinity assay |
US20070072169A1 (en) * | 2005-09-29 | 2007-03-29 | Combimatrix Corporation | Process and apparatus for measuring binding events on a microarray of electrodes |
US20070231794A1 (en) * | 2005-09-21 | 2007-10-04 | Combimatrix Corporation | Process to detect binding events on an electrode microarray using enzymes |
Family Cites Families (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE791653A (en) | 1971-12-28 | 1973-05-21 | Texaco Development Corp | ELECTROLYTIC PROCESS FOR THE PREPARATION OF ACID |
US3950357A (en) | 1974-11-25 | 1976-04-13 | Merck & Co., Inc. | Antibiotics |
US4165320A (en) | 1977-01-17 | 1979-08-21 | E. R. Squibb & Sons, Inc. | Amino acid derivatives |
US4563263A (en) | 1982-01-15 | 1986-01-07 | Terumo Corporation | Selectively permeable film and ion sensor |
US4840893A (en) * | 1983-12-16 | 1989-06-20 | Medisense, Inc. | Electrochemical assay for nucleic acids and nucleic acid probes |
US5268266A (en) * | 1984-05-07 | 1993-12-07 | Genetics Institute, Inc. | Process and nucleic acid construct for producing reagent complexes useful in determining target nucleotide sequences |
US5912339A (en) | 1986-10-28 | 1999-06-15 | The Johns Hopkins University | Oligonucleoside alkyl or arylphosphonate derivatives capable of crosslinking with or cleaving nucleic acids |
US5525464A (en) | 1987-04-01 | 1996-06-11 | Hyseq, Inc. | Method of sequencing by hybridization of oligonucleotide probes |
US5540828A (en) | 1987-06-08 | 1996-07-30 | Yacynych; Alexander | Method for making electrochemical sensors and biosensors having a polymer modified surface |
US6306594B1 (en) | 1988-11-14 | 2001-10-23 | I-Stat Corporation | Methods for microdispensing patterened layers |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US6921636B1 (en) | 1991-09-04 | 2005-07-26 | Metrigen, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
US6017696A (en) | 1993-11-01 | 2000-01-25 | Nanogen, Inc. | Methods for electronic stringency control for molecular biological analysis and diagnostics |
US5605662A (en) | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
US5846708A (en) | 1991-11-19 | 1998-12-08 | Massachusetts Institiute Of Technology | Optical and electrical methods and apparatus for molecule detection |
US5667667A (en) | 1992-04-24 | 1997-09-16 | Isis Innovation Limited | Electrochemical treatment of surfaces |
FR2707010B1 (en) * | 1993-06-25 | 1995-09-29 | Bio Merieux | |
GB9315847D0 (en) | 1993-07-30 | 1993-09-15 | Isis Innovation | Tag reagent and assay method |
US5824473A (en) * | 1993-12-10 | 1998-10-20 | California Institute Of Technology | Nucleic acid mediated electron transfer |
US5928905A (en) | 1995-04-18 | 1999-07-27 | Glaxo Group Limited | End-complementary polymerase reaction |
AU3143695A (en) | 1994-07-25 | 1996-02-22 | Hybridon, Inc. | Improved methods of detritylation for oligonucleotide synthesis |
DE4427921C2 (en) * | 1994-08-06 | 2002-09-26 | Forschungszentrum Juelich Gmbh | Chemical sensors, especially biosensors, based on silicon |
US6066448A (en) | 1995-03-10 | 2000-05-23 | Meso Sclae Technologies, Llc. | Multi-array, multi-specific electrochemiluminescence testing |
WO1996028248A1 (en) | 1995-03-15 | 1996-09-19 | City Of Hope | Disposable reagent storage and delivery cartridge |
US6013440A (en) | 1996-03-11 | 2000-01-11 | Affymetrix, Inc. | Nucleic acid affinity columns |
ZA975891B (en) | 1996-07-05 | 1998-07-23 | Combimatrix Corp | Electrochemical solid phase synthesis of polymers |
US5953681A (en) | 1996-07-30 | 1999-09-14 | Bayer Corporation | Autonomous node for a test instrument system having a distributed logic nodal architecture |
US6391558B1 (en) * | 1997-03-18 | 2002-05-21 | Andcare, Inc. | Electrochemical detection of nucleic acid sequences |
EP1420252A3 (en) | 1997-12-30 | 2004-08-04 | Remacle, José | Detection and/or quantification method of a target molecule by binding with a capture molecule fixed on the surface of a disc |
US20030050438A1 (en) | 1998-01-05 | 2003-03-13 | Montgomery Donald D. | Electrochemical solid phase synthesis |
US6456942B1 (en) | 1998-01-25 | 2002-09-24 | Combimatrix Corporation | Network infrastructure for custom microarray synthesis and analysis |
US6780582B1 (en) | 1998-07-14 | 2004-08-24 | Zyomyx, Inc. | Arrays of protein-capture agents and methods of use thereof |
US6344333B2 (en) * | 1998-09-08 | 2002-02-05 | Synectig Corporation | Reagent-free immunoassay monitoring electrode assembly |
EP1728860B1 (en) | 1999-02-19 | 2010-01-27 | febit holding GmbH | Method for producing polymers |
WO2000051721A2 (en) | 1999-03-01 | 2000-09-08 | Combimatrix Corporation | Combinatorial chelator array |
WO2000053617A1 (en) | 1999-03-08 | 2000-09-14 | Protogene Laboratories, Inc. | Methods and compositions for economically synthesizing and assembling long dna sequences |
CN1185492C (en) * | 1999-03-15 | 2005-01-19 | 清华大学 | Single-point strobed micro electromagnetic units array chip or electromagnetic biologic chip and application thereof |
WO2001023082A2 (en) | 1999-09-30 | 2001-04-05 | Nanogen, Inc. | Biomolecular attachment sites on microelectronic arrays |
US6518024B2 (en) * | 1999-12-13 | 2003-02-11 | Motorola, Inc. | Electrochemical detection of single base extension |
JP4061801B2 (en) | 2000-01-24 | 2008-03-19 | 住友化学株式会社 | Chemically amplified positive resist composition |
US6824669B1 (en) * | 2000-02-17 | 2004-11-30 | Motorola, Inc. | Protein and peptide sensors using electrical detection methods |
US7019129B1 (en) | 2000-05-09 | 2006-03-28 | Biosearch Technologies, Inc. | Dark quenchers for donor-acceptor energy transfer |
US6824988B2 (en) * | 2000-05-15 | 2004-11-30 | R.E.D. Laboratories, N.V. | Method and compositions for use in diagnosing and characterizing chronic immune disease |
WO2002057200A2 (en) | 2000-08-15 | 2002-07-25 | Bioforce Nanosciences, Inc. | Nanoscale molecular arrayer |
WO2002031463A2 (en) | 2000-08-31 | 2002-04-18 | Motorola, Inc. | High density column and row addressable electrode arrays |
DE10049901C2 (en) | 2000-10-10 | 2003-01-02 | Aventis Res & Tech Gmbh & Co | Apparatus and method for electrically accelerated immobilization and for detection of molecules |
WO2002042259A2 (en) | 2000-11-27 | 2002-05-30 | University Of Maryland, Baltimore | Methods of synthesizing and using derivatives of [2-(2-aminoethoxy)ethoxy] acetic acid |
US6743564B2 (en) | 2000-12-07 | 2004-06-01 | Shin-Etsu Chemical Co., Ltd. | Amine compounds, resist compositions and patterning process |
WO2002079514A1 (en) | 2001-01-10 | 2002-10-10 | The Trustees Of Boston College | Dna-bridged carbon nanotube arrays |
EP1390732A4 (en) | 2001-04-03 | 2006-09-27 | Combimatrix Corp | Overlying electrode for electrochemical microarrays |
US6320041B1 (en) | 2001-04-13 | 2001-11-20 | Trilink Biotechnologies, Inc. | Pre-activated carbonyl linkers for the modification of oligonucleotides |
US20050040042A1 (en) | 2001-06-14 | 2005-02-24 | Yun Jae-Young | Method and device for electronic control of the spatial location of charged molecules |
US20030022150A1 (en) * | 2001-07-24 | 2003-01-30 | Sampson Jeffrey R. | Methods for detecting a target molecule |
GB0121155D0 (en) | 2001-08-31 | 2001-10-24 | Isis Innovation | Treatment of substrates |
US7858321B2 (en) | 2001-09-10 | 2010-12-28 | Meso Scale Technologies, Llc | Methods and apparatus for conducting multiple measurements on a sample |
US6960298B2 (en) | 2001-12-10 | 2005-11-01 | Nanogen, Inc. | Mesoporous permeation layers for use on active electronic matrix devices |
EP1458907A4 (en) | 2001-12-17 | 2007-05-09 | Michael Strathmann | Combinatorial synthesis on arrays |
CA2477503A1 (en) | 2002-02-27 | 2003-09-04 | Third Wave Technologies, Inc. | Surface modification, linker attachment, and polymerization methods |
US20030194709A1 (en) | 2002-04-10 | 2003-10-16 | Xing Yang | Hydrophobic zone device |
US7563600B2 (en) | 2002-09-12 | 2009-07-21 | Combimatrix Corporation | Microarray synthesis and assembly of gene-length polynucleotides |
US8346482B2 (en) | 2003-08-22 | 2013-01-01 | Fernandez Dennis S | Integrated biosensor and simulation system for diagnosis and therapy |
JP4511162B2 (en) | 2003-12-05 | 2010-07-28 | 株式会社チノー | Fuel cell evaluation system |
US7206012B2 (en) | 2004-03-24 | 2007-04-17 | Lexmark International, Inc. | Memory device on optical scanner and apparatus and method for storing characterizing information on the memory device |
US20050239112A1 (en) | 2004-04-01 | 2005-10-27 | Migenix, Inc. | Methods and processes for attaching compounds to matrices |
US20060105355A1 (en) | 2004-11-18 | 2006-05-18 | Karl Maurer | Electrode array device having an adsorbed porous reaction layer having a linker moiety |
US20060102471A1 (en) | 2004-11-18 | 2006-05-18 | Karl Maurer | Electrode array device having an adsorbed porous reaction layer |
US20080039342A1 (en) | 2005-01-07 | 2008-02-14 | Combimatrix Corporation | Process for transition metal-catalyzed electrochemical allylic alkylation on an electrode array device |
US20060160100A1 (en) | 2005-01-19 | 2006-07-20 | Agency For Science, Technology And Research | Enzymatic electrochemical detection assay using protective monolayer and device therefor |
US20070034513A1 (en) | 2005-03-25 | 2007-02-15 | Combimatrix Corporation | Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array |
US9394167B2 (en) | 2005-04-15 | 2016-07-19 | Customarray, Inc. | Neutralization and containment of redox species produced by circumferential electrodes |
US20070292855A1 (en) | 2005-08-19 | 2007-12-20 | Intel Corporation | Method and CMOS-based device to analyze molecules and nanomaterials based on the electrical readout of specific binding events on functionalized electrodes |
US7541314B2 (en) | 2006-02-24 | 2009-06-02 | Combimatrix Corporation | Microarray having a base cleavable sulfonyl linker |
US20070065877A1 (en) | 2005-09-19 | 2007-03-22 | Combimatrix Corporation | Microarray having a base cleavable succinate linker |
WO2007109228A1 (en) | 2006-03-17 | 2007-09-27 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Apparatus for microarray binding sensors having biological probe materials using carbon nanotube transistors |
US9927434B2 (en) | 2010-01-20 | 2018-03-27 | Customarray, Inc. | Multiplex microarray of serially deposited biomolecules on a microarray |
-
2001
- 2001-08-30 US US09/944,727 patent/US10539561B1/en not_active Expired - Fee Related
-
2002
- 2002-08-27 WO PCT/US2002/028399 patent/WO2003019147A2/en not_active Application Discontinuation
- 2002-08-27 US US10/229,755 patent/US20030082601A1/en not_active Abandoned
- 2002-08-27 AU AU2002341612A patent/AU2002341612A1/en not_active Abandoned
- 2002-08-27 EP EP02775762.4A patent/EP1430154B1/en not_active Expired - Lifetime
-
2019
- 2019-11-20 US US16/689,473 patent/US20200072823A1/en not_active Abandoned
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200051A (en) * | 1988-11-14 | 1993-04-06 | I-Stat Corporation | Wholly microfabricated biosensors and process for the manufacture and use thereof |
US5122244A (en) * | 1990-02-03 | 1992-06-16 | Boehringer Mannheim Gmbh | Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor |
US6090589A (en) * | 1990-12-31 | 2000-07-18 | Promega Corporation | Nucleic acid amplification with DNA-dependent RNA polymerase activity of RNA replicases |
US5679535A (en) * | 1992-03-05 | 1997-10-21 | University Collge Dublin | Apparatus, kit and method for the collection and determination of environmental antigens |
US5807999A (en) * | 1993-02-01 | 1998-09-15 | Mt. Sinai School Of Medicine Of The City University Of New York | Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone H1 and uses therefor |
US6051380A (en) * | 1993-11-01 | 2000-04-18 | Nanogen, Inc. | Methods and procedures for molecular biological analysis and diagnostics |
US5632957A (en) * | 1993-11-01 | 1997-05-27 | Nanogen | Molecular biological diagnostic systems including electrodes |
US5948624A (en) * | 1994-05-11 | 1999-09-07 | Rothschild; Kenneth J. | Methods for the detection and isolation of biomolecules |
US5865972A (en) * | 1995-12-19 | 1999-02-02 | Universite De Geneve | Integrated electrochemical microsensors and microsystems for direct reliable chemical analysis of compounds in complex aqueous solutions |
US6100045A (en) * | 1997-02-10 | 2000-08-08 | Dsm N.V. | Detection of analytes using electrochemistry |
US6093302A (en) * | 1998-01-05 | 2000-07-25 | Combimatrix Corporation | Electrochemical solid phase synthesis |
US20020081588A1 (en) * | 1998-06-24 | 2002-06-27 | Therasense, Inc. | Multi-sensor array for electrochemical recognition of nucleotide sequences and methods |
US6576461B2 (en) * | 1998-08-24 | 2003-06-10 | Therasense, Inc. | Electrochemical affinity assay |
US6303082B1 (en) * | 1999-12-15 | 2001-10-16 | Nanogen, Inc. | Permeation layer attachment chemistry and method |
US20070231794A1 (en) * | 2005-09-21 | 2007-10-04 | Combimatrix Corporation | Process to detect binding events on an electrode microarray using enzymes |
US20070072169A1 (en) * | 2005-09-29 | 2007-03-29 | Combimatrix Corporation | Process and apparatus for measuring binding events on a microarray of electrodes |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030152930A1 (en) * | 2002-02-11 | 2003-08-14 | Matsushita Electric Industrial Co., Ltd. | Method and apparatus for detecting DNA hybridization |
US20100173396A1 (en) * | 2003-09-10 | 2010-07-08 | Abbott Point Of Care Inc. | Amperometric immunosensor |
US8460922B2 (en) | 2003-09-10 | 2013-06-11 | Abbott Point Of Care Inc. | Immunosensor system for blood with reduced interference |
US8309364B2 (en) | 2003-09-10 | 2012-11-13 | Abbott Point Of Care Inc. | Method of performing an immunoassay in blood |
US8808626B2 (en) * | 2003-09-10 | 2014-08-19 | Abbott Point Of Care Inc. | Amperometric immunosensor |
JP2010281840A (en) * | 2003-09-10 | 2010-12-16 | Abbott Point Of Care Inc | Immunoassay device with immuno-reference electrode |
US8168439B2 (en) | 2003-09-10 | 2012-05-01 | Abbott Point Of Care Inc. | Method for measuring an analyte in blood |
US20100167308A1 (en) * | 2003-09-10 | 2010-07-01 | Abbott Point Of Care Inc. | Method for measuring an analyte in blood |
US7195738B2 (en) * | 2004-02-03 | 2007-03-27 | Canon Kabushiki Kaisha | Sensor and detecting method |
US20050170405A1 (en) * | 2004-02-03 | 2005-08-04 | Canon Kabushiki Kaisha | Sensor and detecting method |
US20070248964A1 (en) * | 2004-04-29 | 2007-10-25 | Agency For Science, Technology And Research | Method and Device for Detection of Nucleic Acids and/or Polypetides |
US7655404B2 (en) | 2004-04-29 | 2010-02-02 | Agency For Science, Technology And Research | Method and device for detection of nucleic acids and/or polypeptides |
WO2005106034A1 (en) | 2004-04-29 | 2005-11-10 | Agency For Science, Technology And Research | Method and device for detection of nucleic acids and/or polypeptides |
US8855955B2 (en) * | 2005-09-29 | 2014-10-07 | Custom Array, Inc. | Process and apparatus for measuring binding events on a microarray of electrodes |
US20070072169A1 (en) * | 2005-09-29 | 2007-03-29 | Combimatrix Corporation | Process and apparatus for measuring binding events on a microarray of electrodes |
DE102006051482A1 (en) * | 2006-07-31 | 2008-02-14 | Nikolaus Bartels | Arrangement for detecting substances, manufacturing the arrangement and its use |
US20110039717A1 (en) * | 2006-08-02 | 2011-02-17 | Kwong Gabriel A | Methods and systems for detecting and/or sorting targets |
US8394590B2 (en) | 2006-08-02 | 2013-03-12 | California Institute Of Technology | Capture agents and related methods and systems for detecting and/or sorting targets |
US20110166034A1 (en) * | 2006-08-02 | 2011-07-07 | Kwong Gabriel A | Capture agents and related methods and systems for detecting and/or sorting targets |
US8354231B2 (en) | 2006-08-02 | 2013-01-15 | Cal. Inst. Tech. | Methods and systems for detecting and/or sorting targets |
US20090036324A1 (en) * | 2007-07-16 | 2009-02-05 | Rong Fan | Arrays, substrates, devices, methods and systems for detecting target molecules |
US20090053732A1 (en) * | 2007-07-16 | 2009-02-26 | Ophir Vermesh | Microfluidic devices, methods and systems for detecting target molecules |
US10928389B2 (en) | 2007-07-16 | 2021-02-23 | California Institute Of Technology | Arrays, substrates, devices, methods and systems for detecting target molecules |
WO2009126828A3 (en) * | 2008-04-09 | 2010-03-04 | California Institute Of Technology | Capture agents and related methods and systems for detecting and/or sorting targets |
CN102112626A (en) * | 2008-04-09 | 2011-06-29 | 加州理工学院 | Capture agents and related methods and systems for detecting and/or sorting targets |
US10983116B2 (en) | 2012-08-24 | 2021-04-20 | Yale University | System, device and method for high-throughput multi-plexed detection |
US11066689B2 (en) | 2014-12-03 | 2021-07-20 | IsoPlexis Corporation | Analysis and screening of cell secretion profiles |
US11661619B2 (en) | 2014-12-03 | 2023-05-30 | IsoPlexis Corporation | Analysis and screening of cell secretion profiles |
US11353448B2 (en) | 2015-02-13 | 2022-06-07 | California Institute Of Technology | Methods and compositions for quantifying metabolites and proteins from single cells |
US11493508B2 (en) | 2016-11-11 | 2022-11-08 | IsoPlexis Corporation | Compositions and methods for the simultaneous genomic, transcriptomic and proteomic analysis of single cells |
US11525783B2 (en) | 2016-11-22 | 2022-12-13 | IsoPlexis Corporation | Systems, devices and methods for cell capture and methods of manufacture thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2003019147A3 (en) | 2003-12-11 |
US20200072823A1 (en) | 2020-03-05 |
WO2003019147A2 (en) | 2003-03-06 |
AU2002341612A1 (en) | 2003-03-10 |
EP1430154A2 (en) | 2004-06-23 |
EP1430154A4 (en) | 2005-09-21 |
US10539561B1 (en) | 2020-01-21 |
EP1430154B1 (en) | 2015-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1430154B1 (en) | Enzyme-amplified redox microarray detection process | |
EP1951913B1 (en) | Process to detect binding events on an electrode microarray using enzymes | |
US8855955B2 (en) | Process and apparatus for measuring binding events on a microarray of electrodes | |
US20170121761A1 (en) | Electrical detection of a dna or rna target in a sample | |
US7488607B2 (en) | Electronically readable microarray with electronic addressing function | |
JP2003156493A (en) | Method for immobilizing a plurality of different bonding agents on separated position of solid support | |
US20040023258A1 (en) | Method and system or detecting nucleic acids | |
US20130065780A1 (en) | Label-Free Multiplexing Bioassays Using Fluorescent Conjugated Polymers and Barcoded Nanoparticles | |
US6255048B1 (en) | Highly sensitive fluoroassay | |
US20030203394A1 (en) | Detection of a target in a sample | |
US20050255515A1 (en) | Biomolecular sensors and detection methods utilizing photoinduced charge separation | |
Gębala et al. | Amplified detection of DNA hybridization using post-labelling with a biotin-modified intercalator | |
Nunes Kirchner et al. | Scanning electrochemical microscopy (SECM) based detection of oligonucleotide hybridization and simultaneous determination of the surface concentration of immobilized oligonucleotides on gold | |
US20050266455A1 (en) | Method and microelectronic device for multi-site molecule detection | |
US20050069905A1 (en) | Detection of molecular binding events | |
US20070248964A1 (en) | Method and Device for Detection of Nucleic Acids and/or Polypetides | |
US20020179439A1 (en) | Microelectronic system and method of use and fabrication | |
JP2004537722A (en) | Detection method for detecting the formation or hybridization of a complex between at least two basic molecules on a solid support based on an amplified signal on the support | |
JP2003207505A (en) | Analyzing method of biological molecule | |
DE102013000682B3 (en) | Detecting molecules, involves immobilizing mixtures of two or more different biochemical capture molecules on two or more analytical array positions, and binding two or more different analytes on each array position | |
US20040072223A1 (en) | Method for detecting macromolecular biopolymers by using at least one immobilization unit provided with a marked scavenger molecule | |
Nakano | 3 Scanning Electrochemical Microscopy Imaging of DNA Arrays for High Throughput Analysis Applications | |
Brajter-toth et al. | Figure 5 The reaction cycles leading to the observed current. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: COMBIMATRIX CORPORATION, WASHINGTON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DILL, KILLIAN;REEL/FRAME:013283/0106 Effective date: 20020827 |
|
AS | Assignment |
Owner name: CUSTOMARRAY, INC., WASHINGTON Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:COMBIMATRIX CORPORATION;REEL/FRAME:025653/0142 Effective date: 20100622 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: CUSTOMARRAY, INC., WASHINGTON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:COMBIMATRIX CORPORATION;REEL/FRAME:043311/0847 Effective date: 20161024 |